Morgan Stanley’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

Morgan Stanley’s Portfolio SAVAW Stock Details SAVAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,674	Closed	-$75.3K	–	8051
2024 Q1	$75.3K	Buy	+18,674	New	+$112K	﹤0.01%	6089

Other funds holding SAVAW

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's SAVAW Position: Q2 2024 in Review

Morgan Stanley sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 18,674 shares — an estimated $75.3K sold.

Morgan Stanley first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $75.3K in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

Morgan Stanley reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Morgan Stanley sold 18,674 Cassava Sciences, Inc. Warrant shares in Q2 2024, an estimated $75.3K.
Morgan Stanley first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
Morgan Stanley's Cassava Sciences, Inc. Warrant position peaked at $75.3K in Q1 2024.
3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.